Canadian Cancer Trials Group Bulletins

Group Administrators Office


Canadian Cancer Trials Group Recognition Awards

We are pleased to let you know the recipients of this year's Canadian Cancer Trials Group Recognition Awards:

Joseph Pater Founder's Award for Excellence in Clinical Trials Research, which recognizes an investigator whose leadership and body of work has contributed to significant advances in the understanding, diagnosis, treatment, cure, and prevention of cancer.

2016 Recipient:
Dr. Kathleen Pritchard, Odette Cancer Centre, Toronto

Ralph Meyer Phase III Young Investigator Award, which recognizes an exceptional MD, fellow, or PhD, within 10 years of certification / first faculty appointment or current fellow who has either spent time at Canadian Cancer Trials Group's Central Office, worked on Phase III projects with Disease Site Committees / Endpoint Committees / Working Groups, or who has contributed significantly to the conduct of a Phase III trial at a centre.

2016 Recipient:
Dr. Patricia Tang, Tom Baker Cancer Centre, Calgary

Elizabeth Eisenhauer Early Drug Development Young Investigator Award, which is presented annually to an exceptional MD, fellow, or PhD, within 7 years of certification / first faculty appointment, or current fellow who has either spent time at Canadian Cancer Trials Group's Central Office, worked on projects with the Investigational New Drug Program, or who has contributed significantly to the conduct of an IND trial at a centre.

2016 Recipients:
Dr. Rachel Goodwin, Ottawa Hospital Research Institute
Dr. Marshall Pitz, CancerCare Manitoba, Winnipeg

Investigational New Drug Program Team Award presented to a non-MD team of clinical research associates, nurses, pharmacists and others who participated in any Canadian Cancer Trials Group IND clinical trial to acknowledge their efforts and dedication to the success of clinical trials.

2016 Recipients:
IND.226 Teams - Juravinski Cancer Centre at Hamilton Health Sciences AND Tom Baker Cancer Centre, Calgary

Phase III Program Team Award presented to individual trial teams from Canadian member centres to acknowledge their efforts and dedication to the success of clinical trials.

2016 Recipients:
CO.21 Team - Cross Cancer Institute, Edmonton
MAC.15 Team - BCCA, Vancouver Cancer Centre

Recipients will be presented with a glass award and certificate(s) at the Plenary Session and Recognition Awards Ceremony at Spring Meeting scheduled for Friday, April 29 from 4:30-6:00 pm.

Congratulations to the 2016 award recipients!!